v3.25.2
Stockholders’ (Deficit) Equity (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Equity [Abstract]    
Schedule of Fair Value of Options Granted Black-Scholes-Merton Model

The assumptions used to determine the fair value of options granted in the six months ended June 30, 2025 using the Black-Scholes-Merton option model are as follows:

 

Dividend yield   -%
Risk-free interest rate   4.0 to 4.5%
Expected volatility   93.4 to 105.1%
Expected term in years   5.0 to 6.0

 

The assumptions used to determine the fair value of options granted in the six months ended June 30, 2024 using the Black-Scholes-Merton model are as follows:

 

Dividend yield     - %
Risk-free interest rate     3.62 to 4.23 %
Expected volatility     100 %
Expected term in years     6 to 6.5  

The assumptions used to determine the fair value of options granted in the year ended December 31, 2023, using the Black-Scholes-Merton model are as follows:

 

 

Dividend yield   - %
Risk-free interest rate   3.62 to 4.23 %
Expected volatility (weighted-average and range, if applicable)     100 %
Expected term     6 to 6.5 years  
Schedule of Stock Option and Related Information

A summary of the Company’s stock option activities and related information for the six months ended June 30, 2025 is as follows:

 

Stock Option  No. of Stock
Option
 

Weighted-Average

Grant Date

Fair Value Per

Stock Option

  Weighted-Average
Remaining
Contractual Life
(in Years)
Balance, January 1, 2025   105,090   $98.6    7.8 
Granted   150,934    7.8    9.7 
Forfeited   (95,183)          
Balance, June 30, 2025   160,841   $32.7    9.0 
Vested and expected to vest June 30, 2025   160,841   $32.7    9.0 

A summary of the Company’s stock option activities and related information for the year ended December 31, 2024 is as follows:

 

Stock Option   No. of Stock
Option
    Weighted-
Average Grant
Date Fair Value
Per Stock
Option
    Weighted-
Average
Remaining
Contractual Life
(in Years)
 
January 01, 2024     114,301     $ 108.62       1.65  
Granted     -       -       -  
Exercised     -       -          
Expired     -       -       -  
Cancelled / Forfeited     (9,211)       (76.60)       -  
December 31, 2024     105,090       98.55       0.65  

 

A summary of the Company’s stock option activities and related information for the year ended December 31, 2023 is as follows:

  

Stock Option   No. of Stock
Option
    Weighted-
Average Grant
Date Fair Value
Per Stock Option
    Weighted-
Average
Remaining
Contractual Life
(in Years)
 
January 01, 2023     108,500     $ 105.80       2.02  
Granted     16,837     $ 20.54       1.28  
Exercised     -       -       -  
Expired     -       -       -  
Cancelled / Forfeited     (11,036 )     (53.46 )     -  
December 31, 2023     114,301     $ 108.62       1.65  
Schedule of Options Outstanding

The following options were outstanding as of June 30, 2025, at their respective exercise price:

 

Exercise Price Options Outstanding 

June 30,

2025

$2.22   23,781 
$6.30   5,731 
$6.40   7,326 
$8.00   32,700 
$9.68   46,512 
$31.20   10,466 
$62.54   6,825 
$133.40   27,500 
Total   160,841 

The following options were outstanding at their respective exercise price:

 

Exercise price options outstanding  December 31, 2024   December 31, 2023 
$31.20   18,265    18,826 
$51.60   17,500    17,500 
$80.00   6,825    15,475 
$133.40   62,500    62,500 
Total   105,090    114,301 
Schedule of Restricted Stock Units

A summary of the Company’s RSU activities and related information for the six months ended June 30, 2025 is as follows:

 

Restricted Stock Units  No. of RSU  

Weighted-Average

Grant Date

Fair Value
Per RSU

   Weighted-Average
Remaining
Contractual Life
(in Years)
 
Balance, January 1, 2025   8,583   $26.20    1.0 
Exercised   (4,292)          
Forfeited   (2,843)          
Balance, June 30, 2025   1,448   $26.20    0.5 

A summary of the Company’s RSU activities and related information for the year ended December 31, 2024 is as follows:

 

Restricted Stock Units  No. of RSU   Weighted-
Average Grant
Date Fair Value
Per RSU
   Weighted-
Average
Remaining
Contractual
Life
(in Years)
 
January 01, 2024   16,175   $26.20    2.00 
Granted   -    -    - 
Vested   (5,392)   26.20    - 
Expired   -    -      
Cancelled / Forfeited   (2,200)   26.20    - 
December 31, 2024   8,583    26.20    1.00 

 

A summary of the Company’s RSU activities and related information for the year ended December 31, 2023 is as follows:

 

Restricted Stock Units  No. of RSU   Weighted-
Average Grant
Date Fair Value
Per RSU
   Weighted-
Average
Remaining
Contractual
Life
(in Years)
 
January 01, 2023   -   $-    - 
Granted   80,001    19.72    2.00 
Vested   (63,311)   (18.02)   - 
Expired   -    -    - 
Cancelled / Forfeited   (515)   (26.20)   - 
December 31, 2023   16,175   $26.20    2.00 
Schedule of Exercise Price of Restricted Stock Units  

The following RSU were outstanding at their respective vest price:

 

Vest price RSU outstanding  December 31, 2024   December 31, 2023 
$26.20   8,583    16,175 
Total   8,583    16,175